Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults

被引:15
|
作者
Reid, Michael [1 ]
Ma, Yifei [1 ]
Scherzer, Rebecca [1 ,2 ]
Price, Jennifer C. [1 ]
French, Audrey L. [3 ,4 ]
Plankey, Michael W. [5 ]
Grunfeld, Carl [1 ,2 ]
Tien, Phyllis C. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Dept Veteran Affairs Med Ctr, Med Serv, San Francisco, CA USA
[3] Stroger Hosp, Dept Med, Chicago, IL USA
[4] Rush Univ, Chicago, IL 60612 USA
[5] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA
关键词
hepatitis C virus; HIV; inflammation; insulin resistance; microbial translocation; monocyte activation; WOMENS INTERAGENCY HIV; ANTIRETROVIRAL THERAPY EXPOSURE; HOMEOSTASIS MODEL ASSESSMENT; TYPE-2; DIABETES-MELLITUS; GLUCOSE CLAMP TECHNIQUE; SOLUBLE CD163; MICROBIAL TRANSLOCATION; IMMUNE ACTIVATION; RISK; OBESITY;
D O I
10.1097/QAD.0000000000001345
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: HIV/hepatitis C virus (HCV) coinfection is associated with insulin resistance, but the mechanism is unclear. We hypothesized that intestinal epithelial damage and the consequent monocyte/macrophage activation and inflammation explain this perturbation. Design: Cross-sectional study of 519 adults (220 HIV+/HCV-; 64 HIV-/HCV+; 89 HIV+/HCV+; 146 HIV-/HCV-). Methods: We used multivariable linear regression to evaluate associations of HIV and HCV with the homeostasis model assessment of insulin resistance (HOMA-IR) and if intestinal fatty (FA) acid binding protein (I-FABP, a marker of gut epithelial integrity), soluble CD14 (sCD14) and soluble CD163 (sCD163) (markers of monocyte/macrophage activation), and IL-6 (an inflammatory cytokine) mediated this association. Results: HIV+/HCV+ and HIV-/HCV+ had greater demographic-adjusted HOMA-IR [mean (95% confidence interval (CI)): 1.96 (1.51, 2.54) and 1.65 (1.22, 2.24)] than HIV+/HCV- and HIV-/HCV- [1.41 (1.18, 1.67) and 1.44 (1.17, 1.75), respectively]. After additional adjustment for lifestyle and metabolic factors, HIV+/HCV+ remained associated with 36% (95% CI: 4, 80%) greater HOMA-IR relative to HIV+/HCV+, whereas HIV-/HCV+ and HIV+/HCV- had smaller differences. Adjustment for sCD163 substantially attenuated the difference between HIV+/HCV+ and HIV-/HCV+; adjustment for I-FABP, sCD14, and IL-6 had little effect. Higher sCD163 was independently associated with 19% (95% CI: 7, 33%), 26% (95% CI: 15, 39%), 25% (95% CI: 14, 37%), and 23% (95% CI: 11, 36%) greater HOMA-IR in HIV+/HCV+, HIV-/HCV+, HIV+/HCV-, and HIV-/HCV- (all estimates per doubling of sCD163). I-FABP, sCD14, and IL-6 were not associated with HOMA-IR. Conclusion: HIV/HCV coinfection is associated with greater HOMA-IR, even after controlling for demographic, lifestyle, and metabolic factors. sCD163, which appears independent of intestinal epithelial damage and inflammation, partly explains this association. Our findings that the association of sCD163 with HOMA-IR occurred even in the absence of HIV and HCV, indicate that viral and nonviral factors affect sCD163 levels. Its role in insulin resistance needs elucidation. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:385 / 393
页数:9
相关论文
共 50 条
  • [41] Coinfection with hepatitis C virus prolongs survival in HIV-infected patients
    El-Serag, H
    Giordano, T
    Souchek, J
    Kramer, J
    Richardson, P
    GASTROENTEROLOGY, 2004, 126 (04) : A677 - A677
  • [42] Change of insulin resistance in hepatitis C virus-infected patients receiving pegylated interferon plus ribavirin
    Hsu, Ming-Hung
    Tseng, Cheng-Hao
    Hsu, Yao-Chun
    Chang, Chi-Yang
    Lin, Chih-Wen
    Lin, Jaw-Town
    Mo, Lein-Ray
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 387 - 388
  • [43] Change of Insulin Resistance in Hepatitis C Virus-infected Patients Receiving Pegylated Interferon Plus Ribavirin
    Tseng, Cheng-Hao
    Hsu, Yao-Chun
    Chang, Chi-Yang
    Lin, Chih-Wen
    Lin, Jaw-Town
    Mo, Lein-Ray
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : E117 - E117
  • [44] Naringenin ameliorates insulin resistance by modulating endoplasmic reticulum stress in hepatitis C virus-infected liver
    Jia, Benli
    Wang, Yong
    Yu, Gang
    Cheng, Yunsheng
    Yang, Chuang
    Cao, Feng
    He, Yan
    Cao, Pengwei
    Meng, Xiangling
    Yu, Dongsheng
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 115
  • [45] Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of β-cells
    Haugaard, SB
    Andersen, O
    Storgaard, H
    Dela, F
    Holst, JJ
    Iversen, J
    Nielsen, JO
    Madsbad, S
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 287 (04): : E677 - E685
  • [46] Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients
    Bollepalli, Srigayatri
    Mathieson, Kathleen
    Bay, Curt
    Hillier, Amy
    Post, John
    Van Thiel, David H.
    Nadir, Abdul
    SEXUALLY TRANSMITTED DISEASES, 2007, 34 (06) : 367 - 370
  • [47] Clinical Factors Associated with Hepatitis A Virus Seropositivity in HIV-Infected Adults Living in a Country with an Epidemiologic Shift for Hepatitis A Virus Infection
    Baek, Ji Hyeon
    Kim, Chang Oh
    Park, Jun Yong
    Jeong, Su Jin
    Koo, Nam Soo
    Kim, Hye Won
    Han, Sang Hoon
    Choi, Jun Yong
    Song, Young Goo
    Kim, June Myung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (08) : 969 - 971
  • [48] PERIPHERAL NEUROPATHY ASSOCIATED WITH CRYOGLOBULINEMIA BUT NOT RELATED TO HEPATITIS-C VIRUS IN AN HIV-INFECTED PATIENT
    LELOSTEC, Z
    FEGUEUX, S
    VITALE, C
    GEOFFROY, O
    BLETON, F
    MORNET, P
    AIDS, 1994, 8 (09) : 1351 - 1352
  • [49] Hepatitis C virus and cumulative infections are associated with atherogenic cardiovascular events in HIV-infected subjects
    Genebat, Miguel
    Tarancon-Diez, Laura
    Pulido, Ildefonso
    Alvarez-Rios, Ana I.
    Angeles Munoz-Fernandez, Maria
    Ruiz-Mateos, Ezequiel
    Leal, Manuel
    ANTIVIRAL RESEARCH, 2019, 169
  • [50] Management of hepatitis C in HIV-infected persons
    Rodríguez-Rosado, R
    Pérez-Olmeda, M
    García-Samaniego, J
    Soriano, V
    ANTIVIRAL RESEARCH, 2001, 52 (02) : 189 - 198